Assessment of Clinical Trials for Devices Intended to Control Myopia Progression in Children

Area of Science:

• Ophthalmology
• Pediatric Optometry
• Clinical Research Design

Background:

• Myopia (nearsightedness) prevalence is increasing globally, posing risks for serious vision impairment.
• Childhood myopia progression is a key concern, driving research into effective interventions.
• Current treatments like pharmacological agents, multifocal spectacles, and contact lenses show potential but require further validation.

Purpose of the Study:

• To review existing studies on myopia control treatments in children.
• To identify limitations in previous clinical trial designs for myopia control.
• To discuss essential study design and regulatory considerations for future research.

Main Methods:

• Review of key published clinical trials on myopia control.
• Analysis of common limitations in study methodologies (e.g., follow-up duration, randomization, masking).
• Discussion of best practices for designing robust clinical trials.

Main Results:

• Previous myopia control studies, particularly those using contact lenses, often suffer from methodological weaknesses.
• Short follow-up times, inadequate randomization, and incomplete masking limit the reliability of past findings.
• A need exists for well-designed studies to establish safety and efficacy of myopia control interventions.

Conclusions:

• Robust clinical study designs are crucial for accurately assessing myopia control treatments.
• Future trials must address methodological limitations to provide reliable evidence on the efficacy and safety of interventions like contact lenses.
• Improved study designs will facilitate regulatory approval and clinical adoption of effective myopia management strategies.